Introduction
============

Manganese (Mn) is a mineral element that is both nutritionally essential and potentially toxic.[@b1-dddt-11-2605] In a number of physiologic processes, Mn plays an important role as an element of various enzymes and an activator of other enzymes, like Mn superoxide dismutase (Mn-SOD), the principal antioxidant enzyme in mitochondria.[@b2-dddt-11-2605] Mn is potentially toxic and especially neurotoxic, which leads to a Parkinson's disease-like syndrome called manganism.[@b3-dddt-11-2605],[@b4-dddt-11-2605] Mn causes toxic effects mainly in the brain, and also produces toxicity in liver, lungs, and heart, as well as reproductive organs.[@b5-dddt-11-2605]--[@b8-dddt-11-2605] Mn is metabolized in the liver; therefore, excessive amounts may cause liver toxicity.[@b9-dddt-11-2605],[@b10-dddt-11-2605] Mn can cause an inflammatory response in the lungs, with clinical symptoms including cough, acute bronchitis, and decreased lung functions.[@b11-dddt-11-2605],[@b12-dddt-11-2605] Our previous study showed that endoplasmic reticulum (ER) stress and stress-mediated apoptosis involved in Mn neurotoxicity, while 3-, 4-, or 5-aminosalicylic acids and polyphenolic extract of *Euphorbia supina* attenuate this effect.[@b13-dddt-11-2605]--[@b16-dddt-11-2605]

Flavonoids are phytophenolic compounds with strong antioxidant effects that function against oxidative stress.[@b17-dddt-11-2605] The flavonoid quercetin (Qct; 3,3′,4′,5,7-pentahydroxyflavone) is a typical polyphenolic compound found ubiquitously in fruit, vegetables, nuts, and plant-origin beverages like tea and wine.[@b17-dddt-11-2605] A number of studies have shown that Qct exhibits potential benefits for human health, due to its antioxidative, anti-inflammatory, antimicrobial, antiviral, antiulcerogenic, cytotoxic, antineoplastic, mutagenic, antioxidant, antihepatotoxic, antihypertensive, hypolipidemic, and antiplatelet properties.[@b18-dddt-11-2605]--[@b21-dddt-11-2605] Qct blocks both the cyclooxygenase and lipoxygenase pathways at relatively high concentrations, while at lower concentrations the lipoxygenase pathway is the primary target of inhibitory anti-inflammatory activity.[@b22-dddt-11-2605] Qct has been reported to reduce both oxidative stress in streptozotocin-induced diabetic rats and cisplatin-induced nephrotoxicity.[@b23-dddt-11-2605],[@b24-dddt-11-2605] Qct also plays a protective role in lead-induced inflammatory responses in rat kidney through the reactive oxygen species (ROS)-mediated MAPK and NFκB pathways.[@b25-dddt-11-2605] Qct has a protective effect against acrylamide-induced oxidative stress in rats.[@b26-dddt-11-2605] Recently, the protective role of Qct against hemotoxic and immunotoxic effects of furan in rats was reported.[@b27-dddt-11-2605] Qct has protective effects against hepatic injury by increasing plasma antioxidant capacity.[@b28-dddt-11-2605],[@b29-dddt-11-2605] Qct has been reported as radioprotective in mice lung via suppression of NFκB and MAPK pathways.[@b30-dddt-11-2605] Therefore, we investigated the protective effects of Qct against Mn-induced toxicity in the liver, kidney, and lung and hematological parameters in acute and subchronic rat models.

Materials and methods
=====================

Experimental animals
--------------------

Seven-week-old Sprague Dawley male rats weighing 220--250 g each were purchased from Damool Science (Daejeon, South Korea). They were kept in clean and dry polypropylene cages on a 12-hour light--dark cycle at 25°C±2°C and 45%--55% relative humidity in the animal house of the Pharmacology Department, Chonbuk National University. The rats were fed a standard laboratory diet and water ad libitum. After a week of adaptation, the rats were randomly divided into four groups. The protocol used for this study in the rat as an animal model was carried out with the guidelines of the Institutional Animal Care and Usage Committee (IACUC), and approval was gained from the ethical committee of Chonbuk National University (CBNU 2016-45).

Acute treatment
---------------

The rats were divided into four groups of six rats each. Rats in group 1 (control group) were injected intraperitoneally (IP) with 0.3 mL of normal saline solution (the solvent for Mn). Rats in group 2 (the Mn group) were injected IP with 0.3 mL of MnCl~2~ (100 mg/kg body weight) in normal saline for 4.5-hour exposure in a single dose. Rats in group 3 (the Mn + Qct~25~ group) were administered MnCl~2~ (100 mg/kg in normal saline) by injection IP after administration of Qct orally (per os \[PO\]; 25 mg/kg in normal saline) for 2.5 hours. Rats in group 4 (the Mn + Qct~50~ group) were administered MnCl~2~ (100 mg/kg in normal saline) by injection IP after administration of Qct PO (50 mg/kg in normal saline) for 2.5 hours. The rats were decapitated after 4.5 hours of injection IP, and blood samples were obtained for biochemical and hematological analyses. Liver, kidney, and lung specimens were fixed in 4% buffered formalin and embedded in paraffin.

Subchronic treatment
--------------------

A subchronic in vivo assay was performed according to the following protocol. Rats were divided into four groups of six rats each. Group 1 (control group) was treated with normal saline solution (every 24 hours for 8 days). Group 2 (Mn group) was administered eight doses of MnCl~2~ (15 mg/kg in normal saline) by injection IP every 24 hours for 8 days. Group 3 (Mn + Qct~25~ group) was administered eight doses of MnCl~2~ (15 mg/kg in normal saline) by injection IP after administration of Qct PO (25 mg/kg in normal saline) every 24 hours for 8 days. Group 4 (Mn + Qct~50~ group) was administered eight doses of MnCl~2~ (15 mg/kg in normal saline) by injection IP after administration of Qct PO (50 mg/kg in normal saline) every 24 hours for 8 days. The rats were killed at the end of the tests. Blood samples were obtained for biochemical and hematological analyses. Liver, kidney, and lung specimens were fixed in 4% buffered formalin and embedded in paraffin.

Biochemical assays
------------------

ALT, AST, and creatinine levels were assessed using detection kits (Jiancheng Institute of Biotechnology, Nanjing, China), based on the manufacturer's instructions.

Hematological studies
---------------------

### Measurement of hematological parameters

An animal blood counter (ABX; Horiba, Kyoto, Japan) was used to analyze the hematological parameters red blood cells (RBCs), hemoglobin (Hb), hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), MCH concentration (MCHC), platelets, and white blood cells (WBCs). Analyses were carried out based on standard methods.[@b54-dddt-11-2605]

### Differential counts of white blood cells

Blood samples were analyzed for differential WBC counts, including lymphocytes, neutrophils, and eosinophils, according to standard methods using the ABX.

### Preparation of peripheral blood smears for visualization of neutrophils and macrophages

Blood neutrophils and macrophages were visualized by peripheral blood smears.[@b58-dddt-11-2605] A blood film or peripheral blood smear is a thin layer of blood smeared on a glass microscope slide and then stained in such a way as to allow the various blood cells (BCs) to be examined microscopically. Briefly, blood films were made by placing a drop of blood on one end of a slide and using a spreader slide to disperse the blood over the slide's length. The slides were left to air-dry, after which the blood was fixed to the slide by immersing it slightly in methanol. After fixation, the slide was stained to distinguish the cells from one another. Diff-Quik, a commercial Romanowsky stain variant, was used to stain rapidly and differentiate a variety of smears, commonly blood and nongynecological smears, including those of fine-needle aspirates.[@b59-dddt-11-2605]--[@b61-dddt-11-2605] Briefly, dipped peripheral blood smears were slid into fixative reagent (triarylmethane dye and methanol), then slides dipped into stain solution 1 (eosin G in phosphate buffer), followed by stain solution 2 (thiazine dye in phosphate buffer), and excess was allowed to drain after each dip. Slides were rinsed in distilled water (pH 7.2) and allowed to dry in air, then visualized under microscopy (Eclipse E600; Nikon, Tokyo, Japan).

Western blot analysis
---------------------

Proteins extracted from tissues (80 µg) were analyzed by Western blot. Briefly, total proteins were extracted and protein concentrations determined using a bicinchoninic acid kit (Intron Biotechnology, Seongnam, South Korea). Protein samples were separated on 10% and 12% polyacrylamide gels and electrotransferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) in a semidried environment. Blots were blocked by 5% defatted milk in Tris buffer containing 0.1% Tween 20 and then incubated with primary antibodies: anti-GRP78 (1:1,000, SC-13539; Santa Cruz Biotechnology, Dallas, TX, USA), anti-CHOP (1:1,000, L63F7, 2895s; Cell Signaling Technology, Danvers, MA, USA), anti-cleaved caspase-3 (1:1,000, Asp175, 9661s; Cell Signaling Technology), and β-actin (A5441; Sigma-Aldrich, St Louis, MO, USA) at 4°C overnight. Subsequently, the blots were incubated with antimouse (\#115-035-003; Jackson ImmunoResearch, West Grove, PA, USA), antigoat (SC-2020; Santa Cruz Biotechnology), and/or antirabbit (SC-2004; Santa Cruz Biotechnology) secondary antibodies at room temperature for 1 hour. Then, blots were developed with EZ-WestLumi Plus solution (Atto, Tokyo, Japan) and analyzed with Ez-Capture ST (Atto).

Collection of tissue slices
---------------------------

The rats were deeply anesthetized with ketamine and perfused transcardially with 100 mL normal saline (0.9%). Liver, kidney, and lung specimens were fixed in 4% buffered formalin and embedded in paraffin. Sections (14 µm) from paraffin-embedded tissue blocks were cut using a microtome (RM2125 rotary; Leica Microsystems, Wetzlar, Germany) and collected on silane-coated slides (Muto Pure Chemical, Tokyo, Japan) for histology and immunohistochemistry and stored at −70°C.

Histological assays
-------------------

Liver, kidney, and lung samples were fixed in formalin, paraffin-embedded, and sectioned. Liver, kidney, and lung sections were stained with H&E for routine histological examination. Pathological changes were viewed under light microscopy after staining, and images taken by differential interference contrast inverted microscopy (Nikon) equipped with micromanipulators (Narishige, Tokyo, Japan).

Immunohistochemical staining of 8-OHdG
--------------------------------------

Paraffin-fixed liver, kidney, and lung slices were sectioned, deparaffinized, and rehydrated, and antigen retrieval was performed with Dako retrieval solution (pH 6) in a microwave oven for 30 minutes. Dako peroxidase-blocking solution was used to block endogenous peroxidase activity for 10 minutes. Dako protein-blocking solution was used to block aspecific protein binding, and tissues were treated with mouse polyclonal anti-8-OHdG (1:500, N45.1, ab48508; Abcam, Cambridge, UK). Subsequently, these were incubated with biotinylated goat antimouse (1:30, D 0314; Dako) immunoglobulins and later visualized with substrate chromogen (K3464; Dako), followed by hematoxylin and mounted with aqueous mount medium. The sections were dehydrated and placed under coverslips, viewed under microscopy, and images taken with differential interference contrast inverted microscopy equipped with micromanipulators.

Statistical analysis
--------------------

All data are expressed as means ± SD, and one-way analysis of variance (ANOVA) followed by Dunnett's test was used for statistical analysis using SPSS software (version 16). *P*\<0.01 and *P*\<0.001 were considered significant.

Results
=======

Effect of Qct on blood biochemical parameters in Mn-treated rats
----------------------------------------------------------------

Mn treatment resulted in significant (*P*\<0.001) increases in ALT, AST, and creatinine levels when compared with controls in acute ([Figure 1](#f1-dddt-11-2605){ref-type="fig"}) and subchronic ([Figure 2](#f2-dddt-11-2605){ref-type="fig"}) rats. Interestingly, Qct pretreatment significantly (*P*\<0.01 or 0.001) reduced ALT ([Figures 1A](#f1-dddt-11-2605){ref-type="fig"} and [2A](#f2-dddt-11-2605){ref-type="fig"}), AST ([Figures 1B](#f1-dddt-11-2605){ref-type="fig"} and [2B](#f2-dddt-11-2605){ref-type="fig"}), and creatinine ([Figures 1C](#f1-dddt-11-2605){ref-type="fig"} and [2C](#f2-dddt-11-2605){ref-type="fig"}) levels relative to the Mn group.

Effect of Qct on hematological parameters
-----------------------------------------

### Effect of Qct on complete blood count in Mn-treated rats

A complete blood count (CBC) is a blood test used to evaluate our overall health and detect a wide range of disorders. Abnormal increases or decreases in cell counts revealed in a CBC may indicate medical conditions that call for further evaluation. The effect of Qct on CBC -- RBCs, Hb, Hct, MCV, MCH, MCHC, platelets, and WBCs -- in acute and subchronic Mn-treated rats are shown in [Tables 1](#t1-dddt-11-2605){ref-type="table"} and [2](#t2-dddt-11-2605){ref-type="table"}. Treatment with Mn significantly (*P*\<0.001) altered CBC, while Mn + Qct groups significantly (*P*\<0.01 or 0.001) reversed Mn-induced alterations in RBCs, Hb, Hct, MCV, MCH, MCHC, platelets, and WBCs.

### Effect of Qct on blood lymphocytes, neutrophils, and eosinophils in Mn-treated rats

Hematological properties of rats exposed to Mn in acute and subchronic groups are shown in [Figures 3](#f3-dddt-11-2605){ref-type="fig"} and [4](#f4-dddt-11-2605){ref-type="fig"}. Treatment with Mn significantly (*P*\<0.01) increased neutrophil ([Figures 3A](#f3-dddt-11-2605){ref-type="fig"} and [4A](#f4-dddt-11-2605){ref-type="fig"}) and eosinophil ([Figures 3C](#f3-dddt-11-2605){ref-type="fig"} and [4C](#f4-dddt-11-2605){ref-type="fig"}) and decreased lymphocyte ([Figures 3B](#f3-dddt-11-2605){ref-type="fig"} and [4B](#f4-dddt-11-2605){ref-type="fig"}) levels relative to the normal control group. However, the Mn + Qct groups showed significantly (*P*\<0.01 or 0.001) decreased neutrophil ([Figures 3A](#f3-dddt-11-2605){ref-type="fig"} and [4A](#f4-dddt-11-2605){ref-type="fig"}) and eosinophil ([Figures 3C](#f3-dddt-11-2605){ref-type="fig"} and [4C](#f4-dddt-11-2605){ref-type="fig"}) and increased lymphocyte ([Figures 3B](#f3-dddt-11-2605){ref-type="fig"} and [4B](#f4-dddt-11-2605){ref-type="fig"}) levels when compared to the Mn group.

### Countereffect of Qct on blood macrophages and neutrophils in Mn-treated rats

Macrophages and neutrophils are involved in the activation of innate immunity, and represent hallmarks of toxicity. Our results showed that macrophages and neutrophils were more abundant in Mn-treated rats, while Qct treatment countered the effect in both the acute ([Figure 5](#f5-dddt-11-2605){ref-type="fig"}) and subchronic ([Figure 6](#f6-dddt-11-2605){ref-type="fig"}) models.

Beneficial effect of Qct against Mn-induced ER stress and ER stress-mediated apoptosis in acute and subchronic models
---------------------------------------------------------------------------------------------------------------------

Western blot analyses were performed to investigate the effects of Mn and Qct on the expression of the ER-resident protein GRP78, transcription factor CHOP, and apoptotic hallmark protein caspase-3 in acute ([Figure 7](#f7-dddt-11-2605){ref-type="fig"}) and subchronic ([Figure 8](#f8-dddt-11-2605){ref-type="fig"}) models. Our results revealed that Mn treatment significantly (*P*\<0.001) increased expression of GRP78, CHOP, and caspase-3 proteins. However, Qct treatment significantly (*P*\<0.01 or 0.001) reversed GRP78, CHOP, and caspase-3 activities.

Histopathological observation of Qct treatment in acute and subchronic models
-----------------------------------------------------------------------------

In both acute ([Figure 9](#f9-dddt-11-2605){ref-type="fig"}) and subchronic ([Figure 10](#f10-dddt-11-2605){ref-type="fig"}) models, histopathological observation showed that there were no abnormal morphological changes in the liver, kidney, or lung tissues of the control rats, but the Mn group showed necrosis and tissue degeneration. However, the Mn + Qct groups protected tissues from Mn toxicity and maintained normal tissue architecture ([Figures 9](#f9-dddt-11-2605){ref-type="fig"} and [10](#f10-dddt-11-2605){ref-type="fig"}). In liver histopathology, the control group exhibited normal hepatic histological architecture, but the Mn group displayed morphological alteration of hepatic features, including aggregation of necrotic hepatocytes, inflammation, and necrosis, which were most prominent in the centrilobular region of the hepatic acinus. However, the Mn + Qct groups showed an improvement in hepatic alterations. In kidney histopathology, the control rats exhibited normal renal histological architecture, but the Mn group displayed morphological alteration of renal features, including necrosis in proximal and distal tubules, fragmentation or even disappearance of the brush border, disruption of cytoplasmic organelles, and glomerular injury. Moreover, the Mn + Qct groups showed protection against renal damage with mild--moderate recovery. In lung histopathology, the control group exhibited normal pulmonary architecture, but the Mn group displayed morphological alteration of pulmonary features, including moderate perivascular and peribronchiolar inflammation with granulomatous aggregation and mild neutrophil infiltration in the alveoli. Interestingly, the Mn + Qct groups showed an improvement in pulmonary damage with mild--moderate morphological change.

Immunohistochemical staining of 8-OHdG on Qct treatment in acute and subchronic models
--------------------------------------------------------------------------------------

8-OHdG is a common oxidative stress marker produced by oxidation of DNA bases. 8-OHdG immunoreactivity was significantly increased in rats treated with Mn compared to the control group. Moreover, immunoreactivity was significantly inhibited in groups treated with Qct in the acute and subchronic models ([Figures 11](#f11-dddt-11-2605){ref-type="fig"} and [12](#f12-dddt-11-2605){ref-type="fig"}).

Discussion
==========

Acute and subchronic treatments with Mn induced significant alterations in organ-appearance, biochemical, hematological, and histopathology parameters. Significant progress has been made over the past decade regarding the mechanism by which Mn induces toxicity. Necrosis due to oxidative events has been implicated in provoking Mn-induced toxicity, with differences in mechanisms depending on signaling processes and disposition of Mn in different tissues.[@b31-dddt-11-2605]--[@b33-dddt-11-2605] Studies have suggested a potent antioxidant capable of suppressing oxidative-initiated events within tissue.[@b34-dddt-11-2605],[@b35-dddt-11-2605] The protective effect of natural antioxidants, of which Qct is one, is remarkable on Mn toxicity. Recently, it was found that Qct exhibited beneficial effects in preclinical research against Mn toxicity.[@b34-dddt-11-2605]

Several serum enzymes are used as indicators or markers for hepatocellular injuries, such as ALT and AST.[@b36-dddt-11-2605] Injured on liver release those cytosolic enzymes (ie, ALT and AST) in the blood cause elevation of their concentration in blood.[@b37-dddt-11-2605],[@b38-dddt-11-2605] From liver-function tests, we found that serum ALT and AST were significantly increased in rats treated with Mn. Interestingly, Qct treatment significantly reduced elevated ALT and AST levels in the acute and subchronic models ([Figures 1](#f1-dddt-11-2605){ref-type="fig"} and [2](#f2-dddt-11-2605){ref-type="fig"}).

The kidney is one of the most commonly affected organs after exposure to toxic metals.[@b39-dddt-11-2605] Creatinine, an indicator of kidney function, is increased during kidney failure or nephrotoxicity.[@b40-dddt-11-2605] Our results showed increased creatinine levels in the group treated with Mn, which may have been due to its nephrotoxic effect. Furthermore, Qct treatment significantly reduced creatinine levels in the acute and chronic models ([Figures 3](#f3-dddt-11-2605){ref-type="fig"} and [4](#f4-dddt-11-2605){ref-type="fig"}).

A CBC test measures several components and features of blood, gives information about the production of all BCs, and identifies the patient's oxygen-carrying capacity through the evaluation of RBCs, Hb, Hct, MCV, MCH, MCHC, platelets and WBCs.[@b41-dddt-11-2605] Our result showed that Qct treatment significantly reversed Mn-induced alteration of RBCs, Hb, Hct, MCV, MCH, MCHC, platelets, and WBCs ([Tables 1](#t1-dddt-11-2605){ref-type="table"} and [2](#t2-dddt-11-2605){ref-type="table"}).[@b41-dddt-11-2605]

We found a significant increase in the number of neutrophils and eosinophils and fewer lymphocytes after treatment with Mn in the acute and subchronic model rats ([Figures 3](#f3-dddt-11-2605){ref-type="fig"} and [4](#f4-dddt-11-2605){ref-type="fig"}). Increased neutrophils and eosinophils and fewer lymphocytes act as a causative factor in organ toxicity.[@b42-dddt-11-2605],[@b43-dddt-11-2605] Moreover, Qct treatment significantly attenuated Mn-induced alteration of hematological parameters. Our peripheral blood smears also showed that Mn treatment elevated the number of neutrophils and macrophages, while Qct treatment effectively counteracted this effect ([Figures 5](#f5-dddt-11-2605){ref-type="fig"} and [6](#f6-dddt-11-2605){ref-type="fig"}).[@b44-dddt-11-2605],[@b45-dddt-11-2605]

We examined the effect of Qct on Mn-induced ER stress and ER stress-mediated apoptosis markers, including GRP78, CHOP, and caspase-3. ER-resident protein GRP78 regulates ER stress-signaling pathways, while CHOP and caspase-3 expression is most sensitive to ER stress and led to apoptosis.[@b16-dddt-11-2605],[@b46-dddt-11-2605],[@b47-dddt-11-2605] Our results demonstrated that GRP78, CHOP, and caspase-3 activities were increased with Mn treatment. However, Qct treatment effectively reversed Mn-induced GRP78, CHOP, and caspase-3 activities in acute and subchronic rat models ([Figures 7](#f7-dddt-11-2605){ref-type="fig"} and [8](#f8-dddt-11-2605){ref-type="fig"}).

With regard to the protective effect of Qct against Mn toxicity in acute and subchronic models, we observed histopathological features of liver, kidney, and lung tissue ([Figures 9](#f9-dddt-11-2605){ref-type="fig"} and [10](#f10-dddt-11-2605){ref-type="fig"}). We found that there were no abnormal histological changes in liver, kidney, or lung tissue of the control group, while the Mn group showed remarkable architectural changes in tissue.[@b48-dddt-11-2605],[@b49-dddt-11-2605] The Mn + Qct groups showed a protective effect against Mn toxicity and maintained the normal architecture of the tissues. Recently, it was reported that Qct decreases liver damage in mice with nonalcoholic steatohepatitis, due to its known anti-inflammatory and antioxidant properties.[@b50-dddt-11-2605] Livers in the Mn group showed morphological alteration of hepatic features, especially zonal necrosis around the central vein, compared to the control group, while the Mn + Qct groups displayed protection of hepatic cells with mild--moderate necrotic changes.[@b50-dddt-11-2605] Liu et al suggested that Qct could protect rat kidney against lead-induced injury by improving renal function, attenuating histopathologic changes, reducing ROS production, renewing activities of antioxidant enzymes, and decreasing DNA oxidative damage and apoptosis.[@b51-dddt-11-2605] Kidneys in the Mn group showed histological alteration of renal features, especially glomerular injury, while the Mn + Qct groups exhibited an improvement in renal damage with mild--moderate recovery. Lungs of the Mn group exhibited morphological alteration of pulmonary features, especially granulomatous aggregation around bronchioles, while the Mn + Qct groups displayed protection of pulmonary damage with mild--moderate morphological change.

Oxidative stress is an important factor in the pathogenesis of any diseases, and 8-OHdG is a specific oxidative stress marker for DNA oxidation.[@b52-dddt-11-2605] Our previous study showed significant elevation in 8-OHdG in an Mn-treated group when compared to the control group.[@b15-dddt-11-2605] This elevation of 8-OHdG levels can be described by the formation of excessive ROS due to oxidative alteration of macromolecules and consequent genomic unsteadiness.[@b50-dddt-11-2605],[@b53-dddt-11-2605] In the present study, we found that 8-OHdG expression in the liver, kidney, and lung was elevated in Mn-exposed rats compared to normal control rats in acute and subchronic models. Interestingly, 8-OHdG expression was effectively counteracted in Mn + Qct group rats ([Figures 11](#f11-dddt-11-2605){ref-type="fig"} and [12](#f12-dddt-11-2605){ref-type="fig"}).[@b48-dddt-11-2605],[@b51-dddt-11-2605],[@b54-dddt-11-2605] It has been reported that Qct is a direct antioxidant and potent scavenger of ROS that decrease oxidation of DNA bases by modulation of antioxidant pathways.[@b52-dddt-11-2605]--[@b57-dddt-11-2605] The present study suggests Qct could be a substantially promising organ-protective agent against toxic Mn effects and perhaps against other toxic metals, chemicals, or drugs.

Conclusion
==========

Our study demonstrated that Qct effectively attenuated Mn-induced organ (liver, kidney, and lung) injury through regulation of biochemical and hematological parameters (ALT, AST, creatinine, and CBC), followed by reduction in oxidative damage, ER stress, and ER stress-mediated apoptosis ([Figure 13](#f13-dddt-11-2605){ref-type="fig"}). The present study suggests that Qct could be a substantially promising organ-protective agent against Mn toxic effects and perhaps against other toxic metals, chemicals, or drugs. However, additional studies are needed to determine the exact protective mechanism and long-term benefits of Qct on health.
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![Effect of Qct on blood ALT, AST, and creatinine in acute treatment.\
**Notes:** (**A**) Blood ALT level; (**B**) blood AST level; (**C**) blood creatinine level. Values presented as means ± SD (n=6). ^\#\#^*P*\<0.001 versus control group; \**P*\<0.01, \*\**P*\<0.001 versus Mn group.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig1){#f1-dddt-11-2605}

![Effect of Qct on blood ALT, AST, and creatinine in subchronic treatment.\
**Notes:** (**A**) Blood ALT level; (**B**) blood AST level; (**C**) blood creatinine level. Values presented as means ± SD (n=6). ^\#\#^*P*\<0.001 versus control group; \**P*\<0.01, \*\**P*\<0.001 versus Mn group.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig2){#f2-dddt-11-2605}

![Effect of Qct on lymphocytes, neutrophils, and eosinophils in acute treatment.\
**Notes:** (**A**) Neutrophil levels; (**B**) lymphocyte levels; (**C**) eosinophil levels. Values presented as means ± SD (n=6). ^\#\#^*P*\<0.001 versus control group; \**P*\<0.01, \*\**P*\<0.001 versus Mn group.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig3){#f3-dddt-11-2605}

![Effect of Qct on lymphocytes, neutrophils, and eosinophils in subchronic treatment.\
**Notes:** (**A**) Neutrophil levels; (**B**) lymphocyte levels; (**C**) eosinophil levels. Values presented as means ± SD (n=6). ^\#\#^*P*\<0.001 versus control group; \**P*\<0.01, \*\**P*\<0.001 versus Mn group.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig4){#f4-dddt-11-2605}

![Microscopic observations of the beneficial effect of Qct on blood macrophages and neutrophils in acute Mn-treated rat model.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig5){#f5-dddt-11-2605}

![Microscopic observation of the beneficial effect of Qct on blood macrophages and neutrophils in subchronic Mn-treated rat model.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig6){#f6-dddt-11-2605}

![Western blot analysis of effect of Qct on Mn-induced endoplasmic reticulum stress and stress-mediated apoptosis markers in acute rat model.\
**Notes:** (**A**) Expression of GRP78, CHOP, and caspase-3 proteins in the liver, kidney and lung in different treatment groups; (**B**) normalization of protein expression by relative density analysis of GRP78, CHOP, and caspase-3. Relative density expressed as ratios (GRP78, CHOP, and caspase-3/β-actin). ^\#\#^*P*\<0.001 versus control group; \**P*\<0.01, \*\**P*\<0.001 versus Mn group.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig7){#f7-dddt-11-2605}

![Western blot analysis of effect of Qct on Mn-induced endoplasmic reticulum stress and stress-mediated apoptosis markers in subchronic rat model.\
**Notes:** (**A**) Expression of GRP78, CHOP, and caspase-3 proteins in the liver, kidney, and lung in different treatment groups; (**B**) normalization of protein expression by relative density analysis of GRP78, CHOP, and caspase-3. Relative density expressed as ratios (GRP78, CHOP, and caspase-3/β-actin). ^\#\#^*P*\<0.001 versus control group; \**P*\<0.01, \*\**P*\<0.001 versus Mn group.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig8){#f8-dddt-11-2605}

![Histopathological images showing beneficial effect of Qct against Mn-induced damage in liver, kidney, and lung in acute model.\
**Notes:** Hepatic histopathology revealed that Mn treatment led to morphological alteration of hepatic features (arrow indicates zonal necrosis around central vein) compared to control group, while Mn + Qct groups showed an improvement tissue, with mild necrotic changes. Renal histopathology revealed that control Mn treatment led to morphological alteration of renal features (arrows indicate glomerular injury) compared with control group, while Mn + Qct groups exhibited protection of tissue, with mild glomerular injury. Pulmonary lung histopathology revealed that Mn treatment led to morphological alteration of lung features (arrow indicates granulomatous aggregation around bronchiole) while Mn + Qct groups exhibited protection of tissue with mild granulomatous aggregation around bronchioles.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig9){#f9-dddt-11-2605}

![Histopathological images showing beneficial effect of Qct against Mn-induced damage in liver, kidney, and lung in subchronic model.\
**Notes:** Hepatic histopathology revealed that Mn treatment led to morphological alteration of hepatic features (arrow indicates zonal necrosis around central vein) compared to control group, while Mn + Qct groups showed an improvement in tissue, with mild necrotic changes. Renal histopathology revealed that control Mn treatment led to morphological alteration of renal features (arrows indicate glomerular injury) compared with control group, while Mn + Qct groups exhibited protection of tissue, with mild glomerular injury. Pulmonary lung histopathology revealed that Mn treatment led to morphological alteration of lung features (arrow indicates granulomatous aggregation around bronchiole), while Mn + Qct groups exhibited protection of tissue, with mild granulomatous aggregation around bronchioles.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig10){#f10-dddt-11-2605}

![Immunohistochemical observation of the beneficial effect of Qct against Mn-induced oxidative marker 8-OHdG in acute model.\
**Notes:** Qct treatment showed protective effect of Qct on Mn-induced oxidative stress compared to control group. The Mn group exhibited 8-OHdG immunoreactivity relative to control group, while Mn + Qct groups attenuated 8-OHdG immunoreactivity.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig11){#f11-dddt-11-2605}

![Immunohistochemical observation of beneficial effect of Qct against Mn-induced oxidative marker 8-OHdG in subchronic model.\
**Notes:** Qct treatment showed protective effect of Qct on Mn-induced oxidative stress compared to control group. The Mn group exhibited 8-OHdG immunoreactivity relative to control group, while Mn + Qct groups attenuated 8-OHdG immunoreactivity.\
**Abbreviations:** Mn, manganese; Qct, quercetin.](dddt-11-2605Fig12){#f12-dddt-11-2605}

![The proposed mechanism of the protective role of Qct against Mn-induced tissue (liver, kidney, and lung) injury.\
**Notes:** High acute dose or chronic exposure of Mn causes alteration of biochemical and hematological parameters, including AST, ALT, creatinine, and CBC, which leads to induction of neutrophil and macrophage activities, followed by oxidative stress (8-OHdG). Oxidative stress leads to ER stress and ER stress-mediated apoptosis proteins (GRP78, CHOP, and caspase-3), resulting in tissue (liver, kidney, and lung) injury. Qct effectively attenuates Mn-induced organ (liver, kidney, and lung) injury through regulation of biochemical and hematological parameters (ALT, AST, creatinine, and CBC), followed by reduction of oxidative damage, ER stress, and ER stress-mediated apoptosis.\
**Abbreviations:** CBC, complete blood count; ER, endoplasmic reticulum; Mn, manganese; Qct, quercetin.](dddt-11-2605Fig13){#f13-dddt-11-2605}

###### 

Complete blood count of different treatment groups in acute model

  Parameters             Groups                                                                                                                                 
  ---------------------- ------------ -------------------------------------------------------------- ---------------------------------------------------------- -------------------------------------------------------------
  RBC count, ×10^6^/µL   6.29±0.43    3.88±0.12[\#\#](#tfn1-dddt-11-2605){ref-type="table-fn"}       4.92±0.06[\*](#tfn2-dddt-11-2605){ref-type="table-fn"}     5.52±0.11[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}
  Hb, g/dL               12.02±0.62   9.75±0.53[\#\#](#tfn1-dddt-11-2605){ref-type="table-fn"}       10.79±0.07[\*](#tfn2-dddt-11-2605){ref-type="table-fn"}    11.21±0.5[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}
  Hct, %                 32.2±0.57    21.74±0.47[\#\#](#tfn1-dddt-11-2605){ref-type="table-fn"}      26.2±0.1[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}    28.56±0.58[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}
  MCV, fL                50±1.1       56±1.19[\#\#](#tfn1-dddt-11-2605){ref-type="table-fn"}         53±1.8[\*](#tfn2-dddt-11-2605){ref-type="table-fn"}        51±1.1[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}
  MCH, pg                19±1.05      25±1.04[\#\#](#tfn1-dddt-11-2605){ref-type="table-fn"}         21±0.21[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}     20±0.97[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}
  MCHC, gm/dL            37.55±0.59   44.89±0.44[\#\#](#tfn1-dddt-11-2605){ref-type="table-fn"}      41.18±0.26[\*](#tfn2-dddt-11-2605){ref-type="table-fn"}    39.26±1.03[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}
  Platelets, ×10^3^/µL   914.6±8.29   1,418.8±12.69[\#\#](#tfn1-dddt-11-2605){ref-type="table-fn"}   1,269±10.97[\*](#tfn2-dddt-11-2605){ref-type="table-fn"}   1,168.8±13.5[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}
  WBC count, ×10^3^/µL   11.52±0.81   17.43±0.6[\#\#](#tfn1-dddt-11-2605){ref-type="table-fn"}       15.05±0.71[\*](#tfn2-dddt-11-2605){ref-type="table-fn"}    13.56±0.47[\*\*](#tfn3-dddt-11-2605){ref-type="table-fn"}

**Notes:**

*P*\<0.001 compared to control group;

*P*\<0.01,

*P*\<0.001, compared to Mn group. Values expressed as means ± SD (n=6).

**Abbreviations:** RBC, red blood cell; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; Mn, manganese; Qct, quercetin; WBC, white blood cell.

###### 

Complete blood count of different treatment groups in subchronic model

  Parameters             Groups                                                                                                                                   
  ---------------------- -------------- ------------------------------------------------------------- ----------------------------------------------------------- --------------------------------------------------------------
  RBC count, ×10^6^/µL   7.32±0.16      4.53±0.16[\#\#](#tfn5-dddt-11-2605){ref-type="table-fn"}      5.19±0.05[\*](#tfn6-dddt-11-2605){ref-type="table-fn"}      6.16±0.45[\*\*](#tfn7-dddt-11-2605){ref-type="table-fn"}
  Hb, g/dL               14.32±0.84     11.77±0.12[\#\#](#tfn5-dddt-11-2605){ref-type="table-fn"}     12.53±0.38[\*](#tfn6-dddt-11-2605){ref-type="table-fn"}     13.41±0.12[\*\*](#tfn7-dddt-11-2605){ref-type="table-fn"}
  Hct, %                 42.64±0.55     32.98±0.5[\#\#](#tfn5-dddt-11-2605){ref-type="table-fn"}      36.16±0.67[\*](#tfn6-dddt-11-2605){ref-type="table-fn"}     39.16±0.55[\*\*](#tfn7-dddt-11-2605){ref-type="table-fn"}
  MCV, fL                58.30±1.35     72.98±4.07[\#\#](#tfn5-dddt-11-2605){ref-type="table-fn"}     64.05±2.95[\*](#tfn6-dddt-11-2605){ref-type="table-fn"}     60.79±4.12[\*\*](#tfn7-dddt-11-2605){ref-type="table-fn"}
  MCH, pg                19.57±0.57     25.99±0.53[\#\#](#tfn5-dddt-11-2605){ref-type="table-fn"}     22.17±0.33[\*](#tfn6-dddt-11-2605){ref-type="table-fn"}     20.75±0.65[\*\*](#tfn7-dddt-11-2605){ref-type="table-fn"}
  MCHC, gm/dL            35.06±2.72     44.58±1.56[\#\#](#tfn5-dddt-11-2605){ref-type="table-fn"}     38.45±0.78[\*](#tfn6-dddt-11-2605){ref-type="table-fn"}     37.09±0.62[\*\*](#tfn7-dddt-11-2605){ref-type="table-fn"}
  Platelets, ×10^3^/µL   1,045.6±8.08   1,710.8±9.44[\#\#](#tfn5-dddt-11-2605){ref-type="table-fn"}   1,575.2±7.29[\*](#tfn6-dddt-11-2605){ref-type="table-fn"}   1,372.6±10.69[\*\*](#tfn7-dddt-11-2605){ref-type="table-fn"}
  WBC count, ×10^3^/µL   18.32±1.09     27.12±0.69[\#\#](#tfn5-dddt-11-2605){ref-type="table-fn"}     23.93±0.55[\*](#tfn6-dddt-11-2605){ref-type="table-fn"}     21.61±0.42[\*\*](#tfn7-dddt-11-2605){ref-type="table-fn"}

**Notes:**

*P*\<0.001 compared to control group;

*P*\<0.01,

*P*\<0.001 compared to Mn group. Values are expressed as means ± SD (n=6).

**Abbreviations:** RBC, red blood cell; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; Mn, manganese; Qct, quercetin; WBC, white blood cell.
